- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05708638
Target-controlled Infusion Anesthesia and Post-induction Hypotension
Does Anesthesia Induction With Target-controlled Infusion Reduce Post-induction Hypotension?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Maintaining normotension is one of the top priorities for anesthesiologists due to its negative effects. Although there are a lot of studies and knowledge on the topic approximately 20-30% of patients develop post-induction hypotension. Mostly it occurs due to the adverse effects of anesthetics such as a decrease in systemic vascular resistance or cardiac output and the interplay between them. The risk can be minimized in two steps: first by identifying high-risk patients, and second with tight control of hemodynamic parameters. As a second step, tight hemodynamic control during induction may be done using target-controlled infusion (TCI) systems, which systems help to adjust the dosage to the needs of each patient by measuring hypnotic effects through the bispectral index (BIS).
TCI models for propofol have been previously compared with manual infusions, however, it is not clear whether it still contributes to or triggers hemodynamic deterioration. Therefore in this study, the investigators' aim is to determine the effect of two different anesthesia techniques on the development of postinduction hypotension through hemodynamic parameters monitored by the pressure recording analytical method (PRAM). The secondary aim is to identify risk factors that can predict postinduction hypotension
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 31190
- Acibadem Altunizade Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with the American Society of Anesthesiology physical status 1-3
- Underwent major elective surgery
- Required intra-arterial blood pressure monitoring before induction.
Exclusion Criteria:
- Under 18 years of age
- Arrhythmia (atrial fibrillation, frequent premature beat)
- Severe valvular heart disease
- Morbid obesity
- Intubation difficulty
- Drug addiction
- Treatment with opiates
- Pregnancy
- Emergency surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Patients who were assigned to have manual anesthesia induction group with propofol
Patients who were assigned to have a manual anesthesia induction group, propofol was administered 2-3 mg/kg in 1-2 minutes to achieve a level of hypnosis measured by bispectral index ( BIS ) of 35-60.
|
In manual anesthesia induction, anesthetic agents are administered at a fixed dose and rate adjusted according to the patient's weight
Other Names:
|
|
Active Comparator: Patients who were assigned to have target controlled infusions ( TCI) induction with propofol
Patients who were assigned to have TCI induction had the target effect site concentration (Ce) of propofol (Ce) set at 3 μg ml-1 using the Schneider model and subsequently modified to achieve and maintain a level of hypnosis measured by BIS of 35-55
|
Target controlled infusion (TCI) system aims to reach the theoretically targeted blood or brain concentration of anesthetic agents based on the patient's age, weight, and height, with computer-assisted algorithms.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Systolic arterial pressure (SAP), measured before and after anesthesia induction was assessed to determine of post-induction hypotension in patients undergoing general anesthesia induction with TCI (target controlled infusion) or manual
Time Frame: The duration of the study was defined from one minute before induction to 10 minutes after induction
|
Systolic arterial pressure (SAP- mm/Hg) was monitored using the uncalibrated pulse contour device MostCare (Vytech, Vygon, Padova, Italy).
SAP is a parameter used to assess the pressure of the arterial system during cardiac systole
|
The duration of the study was defined from one minute before induction to 10 minutes after induction
|
|
Diastolic arterial pressure (DAP), measured before and after anesthesia induction was assessed to determine of post-induction hypotension in patients undergoing general anesthesia induction with TCI (target controlled infusion) or manual
Time Frame: The duration of the study was defined from one minute before induction to 10 minutes after induction
|
Diastolic arterial pressure (DAP, mm/Hg) was monitored using the uncalibrated pulse contour device MostCare (Vytech, Vygon, Padova, Italy).
DAP is a parameter used to assess the pressure of the arterial system during cardiac diastole.
|
The duration of the study was defined from one minute before induction to 10 minutes after induction
|
|
Mean arterial pressure (MAP), measured before and after anesthesia induction was assessed to determine of post-induction hypotension in patients undergoing general anesthesia induction with TCI (target controlled infusion) or manual
Time Frame: The duration of the study was defined from one minute before induction to 10 minutes after induction
|
Mean arterial pressure (MAP, mm/Hg) was monitored using the uncalibrated pulse contour device MostCare (Vytech, Vygon, Padova, Italy).
MAP is a parameter used to assess organ perfusion
|
The duration of the study was defined from one minute before induction to 10 minutes after induction
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arterial elastance (Ea) measured before anesthesia induction was investigated whether is a predictive parameter for post-induction hypotension in patients undergoing general anesthesia with TCI or manual
Time Frame: he duration of the study was defined from one minute before induction to 10 minutes after induction
|
Ea ((mmHg m-2ml-1)is an indicator of cardiac afterload and arterial tone and can be calculated by the ratio of the end-systolic pressure (ESP) and stroke volume (SV) obtained from arterial wave analysis.
Ea was monitored using the uncalibrated pulse contour device MostCare (Vytech, Vygon, Padova, Italy) before the anesthesia induction
|
he duration of the study was defined from one minute before induction to 10 minutes after induction
|
|
Stroke volume variation (SVV), measured before anesthesia induction were assessed for prediction of post-induction hypotension in patients undergoing general anesthesia induction with TCI and manual
Time Frame: The duration of the study was defined from one minute before induction to 10 minutes after induction]
|
Stroke volume variation (SVV,%), was monitored using the uncalibrated pulse contour device MostCare (Vytech, Vygon, Padova, Italy).
SVV is a parameter used to asses cardiac preload and fluid responsiveness
|
The duration of the study was defined from one minute before induction to 10 minutes after induction]
|
|
Pulse pressure variation (PPV), measured before anesthesia induction were assessed for prediction of post-induction hypotension in patients undergoing general anesthesia induction with TCI or manual
Time Frame: The duration of the study was defined from one minute before induction to 10 minutes after induction
|
Pulse pressure variation (PPV,%) was monitored using the uncalibrated pulse contour device MostCare (Vytech, Vygon, Padova, Italy).
PPV is a parameter used to asses cardiac preload and fluid responsiveness.
|
The duration of the study was defined from one minute before induction to 10 minutes after induction
|
|
Cardiac power output (CPO), measured before anesthesia induction were assessed for prediction of post-induction hypotension in patients undergoing general anesthesia induction with TCI or manual
Time Frame: The duration of the study was defined from one minute before induction to 10 minutes after induction
|
Cardiac power output (CPO, Watt) was monitored using the uncalibrated pulse contour device MostCare (Vytech, Vygon, Padova, Italy).
CPO is a parameter used to asses cardiac reserve
|
The duration of the study was defined from one minute before induction to 10 minutes after induction
|
|
Cardiac index (CI), measured before anesthesia induction were assessed for prediction of post-induction hypotension in patients undergoing general anesthesia induction with TCI or manual
Time Frame: The duration of the study was defined from one minute before induction to 10 minutes after induction
|
Cardiac index (CI, L/min/m2), was monitored using the uncalibrated pulse contour device MostCare (Vytech, Vygon, Padova, Italy).
CI is a parameter used to asses cardiac stroke volume
|
The duration of the study was defined from one minute before induction to 10 minutes after induction
|
|
Dp/Dt, measured before anesthesia induction were assessed for prediction of post-induction hypotension in patients undergoing general anesthesia induction with TCI or manual
Time Frame: The duration of the study was defined from one minute before induction to 10 minutes after induction
|
Dp/Dt(mmHg/msn), was monitored using the uncalibrated pulse contour device MostCare (Vytech, Vygon, Padova, Italy).
Dp/Dt is a parameter used to asses cardiac contractility.
|
The duration of the study was defined from one minute before induction to 10 minutes after induction
|
|
Heart rate (HR), measured before anesthesia induction were assessed for prediction of post-induction hypotension in patients undergoing general anesthesia induction with TCI or manual
Time Frame: The duration of the study was defined from one minute before induction to 10 minutes after induction
|
Heart rate (HR/bpm) was monitored using the uncalibrated pulse contour device MostCare (Vytech, Vygon, Padova, Italy).
HR is a parameter used to assess the cardiac rate.
|
The duration of the study was defined from one minute before induction to 10 minutes after induction
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, Cywinski J, Thabane L, Sessler DI. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013 Sep;119(3):507-15. doi: 10.1097/ALN.0b013e3182a10e26.
- Mu J, Jiang T, Xu XB, Yuen VM, Irwin MG. Comparison of target-controlled infusion and manual infusion for propofol anaesthesia in children. Br J Anaesth. 2018 May;120(5):1049-1055. doi: 10.1016/j.bja.2017.11.102. Epub 2018 Feb 3.
- Hsieh ML, Lu YT, Lin CC, Lee CP. Comparison of the target-controlled infusion and the manual infusion of propofol anesthesia during electroconvulsive therapy: an open-label randomized controlled trial. BMC Psychiatry. 2021 Feb 4;21(1):71. doi: 10.1186/s12888-021-03069-6.
- Guarracino F, Lapolla F, Cariello C, Danella A, Doroni L, Baldassarri R, Boldrini A, Volpe ML. Target controlled infusion: TCI. Minerva Anestesiol. 2005 Jun;71(6):335-7.
- Leslie K, Clavisi O, Hargrove J. Target-controlled infusion versus manually-controlled infusion of propofol for general anaesthesia or sedation in adults. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006059. doi: 10.1002/14651858.CD006059.pub2.
- Marik PE. Noninvasive cardiac output monitors: a state-of the-art review. J Cardiothorac Vasc Anesth. 2013 Feb;27(1):121-34. doi: 10.1053/j.jvca.2012.03.022. Epub 2012 May 19. No abstract available.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ATADEK 2022-18/04
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on General Anesthesia
-
Universidad de AntioquiaCompletedAnesthesia, General | Anesthesia, IntravenousColombia
-
Children's Hospital of PhiladelphiaErasmus Medical Center; University of Texas Southwestern Medical Center; Children... and other collaboratorsCompletedPediatric Anesthesia | General Anesthesia | ElectroencephalographyUnited States, Australia, Switzerland, China, Netherlands
-
Medipol UniversityCompletedAnesthesia, General | Cesarean Section | Anesthesia, IntravenousTurkey (Türkiye)
-
University Hospital, SaarlandCompletedGeneral Anesthesia | Regional Anesthesia | Immune FunctionGermany
-
Tanta UniversityRecruitingSpinal Anesthesia | General Anesthesia | Inguinal Herniorrhaphy | NeonatesEgypt
-
Nordic Pharma SASCompletedSpinal Anesthesia | Outpatient Surgery | Short General AnesthesiaFrance
-
Armed Forces Hospital, PakistanCompletedGeneral Anesthesia | Epidural AnesthesiaPakistan
-
Jagiellonian UniversityRecruitingAnesthesia, General | Analgesics, Opioid | Anesthesia, EndotrachealPoland
-
Antalya Training and Research HospitalCompletedAnesthesia, General | Anesthesia, Spinal | Umbilical CordTurkey
-
Samsung Medical CenterUnknownGeneral Anesthesia | Total Intravenous Anesthesia | Bispectral Index MonitoringKorea, Republic of
Clinical Trials on Manual anesthesia induction
-
University of PadovaWithdrawnAnesthesia | Stroke, Ischemic | Hemodynamic Instability | Stroke/Brain AttackItaly
-
Acibadem UniversityRecruitingAnesthesia | Hemodynamic InstabilityTurkey
-
Gang ChenNot yet recruitingEndoscopic Retrograde Cholangiopancreatography (ERCP) | Biliary and Pancreatic Diseases
-
Stanford UniversityNot yet recruitingPolyethylene Glycol | Residual Gastric Contents
-
Umeå UniversityCompletedAnesthesia | Airway Complication of Anesthesia | Adverse EffectSweden
-
Tianjin Medical University Cancer Institute and...Shanghai Hengrui Pharmaceutical Co., Ltd.Recruiting
-
Chinese PLA General HospitalCompleted
-
University of FoggiaCompletedPostoperative Cognitive DysfunctionItaly
-
Universidad de AntioquiaUnknownGastric InsufflationColombia
-
Rennes University HospitalNot yet recruiting